Results 1 to 10 of about 21,046 (260)

Sodium Valproate Induces Cell Senescence in Human Hepatocarcinoma Cells

open access: yesMolecules, 2013
Hepatocarcinogenesis is associated with epigenetic changes, including histone deacetylases (HDACs). Epigenetic modulation by HDAC inhibition is a potentially valuable approach for hepatocellular carcinoma treatment.
Bing Hu, Hong-Mei An
exaly   +4 more sources

La resonancia magnética nuclear de la hepatocarcinoma en la cirrosis hepática y los hallazgos de la patología del explante hepático [PDF]

open access: yesRevista de la Facultad de Medicina Humana, 2022
Objetivos: Determinar la sensibilidad y especificidad de la RMN trifásica con gadolinio en la detección de hepatocarcinoma en pacientes cirróticos que fueron a trasplante hepático y su correlación con los hallazgos del estudio patológico del explante ...
Consuelo Elsa Cornejo-Carrasco
doaj   +3 more sources

Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma

open access: yesFrontiers in Oncology, 2019
Caffeic acid (CA) is a phenolic compound synthesized by all plant species and is present in foods such as coffee, wine, tea, and popular medicines such as propolis.
Marta Monteiro
exaly   +3 more sources

Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells

open access: yesAntioxidants, 2019
Sorafenib is the first-line recommended therapy for patients with advanced hepatocarcinoma (HCC) in de-differentiation stage (presenting epithelial−mesenchymal transition, EMT).
Maria José Lopez-Grueso   +2 more
exaly   +3 more sources

Epigenetic repression of de novo cysteine synthetases induces intra-cellular accumulation of cysteine in hepatocarcinoma by up-regulating the cystine uptake transporter xCT [PDF]

open access: yesCancer & Metabolism
Background The metabolic reprogramming of amino acids is critical for cancer cell growth and survival. Notably, intracellular accumulation of cysteine is often observed in various cancers, suggesting its potential role in alleviating the oxidative stress
Tomoaki Yamauchi   +9 more
doaj   +2 more sources

Three Noble Metal Nanoparticles Demonstrated Distinct Biological Interactions and Cell Death Pathways in Human Hepatocarcinoma Cell Lines [PDF]

open access: yesNanotechnology, Science and Applications
Kacper Wiktorowski,1,* Kamila Podsiadło,1,* Nasrin Abbasi Gharibkandi,2 Sylwia Michlewska,3 Katarzyna D Kania,4,5 Aleksander Bilewicz,3 Agnieszka Majkowska-Pilip,3 Marzena Szwed1 1Department of Medical Biophysics, Institute of ...
Wiktorowski K   +7 more
doaj   +2 more sources

Liver Transplantation for Hepatocarcinoma: Results over Two Decades of a Transplantation Programme and Analysis of Factors Associated with Recurrence

open access: yesBiomedicines
Background: In recent years, many studies have attempted to develop models to predict the recurrence of hepatocarcinoma after liver transplantation.
Miguel Jiménez Perez   +1 more
exaly   +3 more sources

33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways

open access: yesJournal of Advanced Research, 2021
Introduction: As a member of annexin family proteins, annexin A3 (ANXA3) has 36-kDa and 33-kDa isoforms. ANXA3 plays crucial roles in the tumorigenesis, aggressiveness and drug-resistance of cancers.
Chunmei Guo   +11 more
doaj   +1 more source

Late Recurrence of Hepatocellular Carcinoma in a Patient 10 Years after Liver Transplantation Unrelated to Transplanted Organ

open access: yesCase Reports in Oncology, 2021
Liver transplantation (LTx) is an accepted method of hepatocellular carcinoma (HCC) treatment in cirrhotic patients; however, it has many limitations, and there is a substantial risk of recurrence.
Kornelia Morisson-Sarapak   +3 more
doaj   +1 more source

Cirrhosis of the liver and hepatocellular carcinoma in the outcome of chronic hepatitis C: a case report

open access: yesЛечащий Врач, 2023
The article presents a clinical case of cirrhosis of the liver of class C according to Child – Pugh in the outcome of chronic hepatitis C and with the development of primary liver cancer.
V. V. Makashova   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy